• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEROYAL CIENTIFICA DE LATINOAMERICA S.R.L ESOPH STETH 400 SERIES 18 FR, 400 SERIES; STETHOSCOPE, ESOPHAGEAL, WITH ELECTRICAL CONDUCTORS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEROYAL CIENTIFICA DE LATINOAMERICA S.R.L ESOPH STETH 400 SERIES 18 FR, 400 SERIES; STETHOSCOPE, ESOPHAGEAL, WITH ELECTRICAL CONDUCTORS Back to Search Results
Model Number 81-040418
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 01/01/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A complaint was found in the literature source "arytenoid dislocation after uneventful endotracheal intubation: a case report" from the journal called korean j anesthesiol reporting, "on the first postoperative day in the ward, she complained of moderate hoarseness.The physician expected the symptom would resolve spontaneously, but the patient complained of persistent hoarseness on the fourth day after the operation.There were no symptoms other than hoarseness.On the sixth day after the operation, fiber-optic laryngoscopy was performed by the laryngologist.On laryngoscopy, the left vocal cord was fixed in the paramedian position, however minimal movement of arytenoid during phonation was observed.Arytenoid dislocation was suspected, and surgical reduction under general anesthesia was performed.The patient's voice was improved immediately after the surgery; and a month after the surgery, movement of the vocal cords was completely normal." (b)(4).The failure mode effect analysis (fmea) was reviewed and updated to reflect this risk.Deroyal also reviewed the material review report (mrr's) and it was confirmed that there were no other mrr's related to this product under investigation.This complaint was found in literature and no contact information was provided therefore no follow-ups were able to be conducted due to the source.While no specific corrective or preventative actions were taken, deroyal will continue to monitor for trends around this issue.This investigation is complete at this time.No further information is available at this time.We will provide follow-up report if additional information becomes available.
 
Event or Problem Description
On the first postoperative day in the ward, she complained of moderate hoarseness.The physician expected the symptom would resolve spontaneously, but the patient complained of persistent hoarseness on the fourth day after the operation.There were no symptoms other than hoarseness.On the sixth day after the operation, fiber-optic laryngoscopy was performed by the laryngologist.On laryngoscopy, the left vocal cord was fixed in the paramedian position, however minimal movement of arytenoid during phonation was observed.Arytenoid dislocation was suspected, and surgical reduction under general anesthesia was performed.The patient's voice was improved immediately after the surgery; and a month after the surgery, movement of the vocal cords was completely normal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESOPH STETH 400 SERIES 18 FR, 400 SERIES
Common Device Name
STETHOSCOPE, ESOPHAGEAL, WITH ELECTRICAL CONDUCTORS
Manufacturer (Section D)
DEROYAL CIENTIFICA DE LATINOAMERICA S.R.L
global park, p.o. box 180-3006
602 parkway,
la aurora, heredia 146
CS  146
Manufacturer (Section G)
DEROYAL CIENTIFICA DE LATINOAMERICA S.R.L
global park, p.o. box 180-3006
602 parkway,
la aurora, heredia 146
CS   146
Manufacturer Contact
reagan newman
200 debusk lane
powell, TN 37849
8653622106
MDR Report Key19929636
Report Number9613793-2023-00002
Device Sequence Number16834354
Product Code BZT
UDI-Device Identifier00749756045988
UDI-Public00749756045988
Combination Product (Y/N)N
PMA/510(K) Number
K193027
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Literature
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number81-040418
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/13/2023
Initial Report FDA Received Date08/07/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-